Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Post-transcriptional control by RNA-binding proteins in diabetes and its related complications. | Front Physiol | 2022 | 36277184 | PubTator, text mining | PubMed |
| Establishment and verification of a prognostic model of liver cancer by RNA-binding proteins based on the TCGA database. | Transl Cancer Res | 2022 | 36249884 | PubTator, text mining | PubMed |
| m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma. | Front Oncol | 2022 | 36249006 | PubTator, text mining | PubMed |
| Intermittent compressive force regulates human periodontal ligament cell behavior via yes-associated protein. | Heliyon | 2022 | 36247165 | PubTator, text mining | PubMed |
| Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. | Front Genet | 2022 | 36246622 | PubTator, text mining | PubMed |
| Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. | Int J Mol Sci | 2022 | 36232796 | PubTator, text mining | PubMed |
| Lin28 Regulates Cancer Cell Stemness for Tumour Progression. | Cancers (Basel) | 2022 | 36230562 | PubTator, text mining | PubMed |
| Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants. | Cancers (Basel) | 2022 | 36230485 | PubTator, text mining | PubMed |
| A review on the role of LINC00467 in the carcinogenesis. | Cancer Cell Int | 2022 | 36229833 | PubTator, text mining | PubMed |
| Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s). | Cancer Res | 2022 | 36214624 | PubTator, text mining | PubMed |
| Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified. | Front Oncol | 2022 | 36212481 | PubTator, text mining | PubMed |
| LncmiRHG-MIR100HG: A new budding star in cancer. | Front Oncol | 2022 | 36212400 | PubTator, text mining | PubMed |
| Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin. | Cancer Res | 2022 | 36206301 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma. | Front Cell Infect Microbiol | 2022 | 36204642 | PubTator, text mining | PubMed |
| From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma. | Front Immunol | 2022 | 36203599 | PubTator, text mining | PubMed |
| LINC00467: an oncogenic long noncoding RNA. | Cancer Cell Int | 2022 | 36203193 | PubTator, text mining | PubMed |
| Identification of the Hub Genes and Potential Regulation Network in Chronic Hepatitis B via Bioinformatics Analysis. | Dis Markers | 2022 | 36193503 | PubTator, text mining | PubMed |
| Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN. | Front Cell Dev Biol | 2022 | 36187481 | PubTator, text mining | PubMed |
| MKRN3 role in regulating pubertal onset: the state of art of functional studies. | Front Endocrinol (Lausanne) | 2022 | 36187104 | PubTator, text mining | PubMed |
| An overview of resistance to chemotherapy in osteosarcoma and future perspectives. | Cancer Drug Resist | 2022 | 36176756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=21